Makino Junya, Asai Rei, Hashimoto Mao, Kamiya Tetsuro, Hara Hirokazu, Ninomiya Masayuki, Koketsu Mamoru, Adachi Tetsuo
Department of Biomedical Pharmaceutics, Laboratory of Clinical Pharmaceutics, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, Gifu 501-1196, Japan.
Department of Chemistry and Biomolecular Science, Faculty of Engineering, Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan.
J Cell Biochem. 2016 Nov;117(11):2496-505. doi: 10.1002/jcb.25542. Epub 2016 Apr 1.
Reactive oxygen species (ROS) produced by endothelial cells and macrophages play important roles in atherogenesis because they promote the formation of oxidized low-density lipoproteins (oxLDL). Extracellular-superoxide dismutase (EC-SOD) is mainly produced by vascular smooth muscle cells (VSMCs), is secreted into the extracellular space, and protects cells from the damaging effects of the superoxide anion. Thus, the expression of EC-SOD in VSMCs is crucial for protecting cells against atherogenesis; however, oxLDL-induced changes in the expression of EC-SOD in VSMCs have not yet been examined. We herein showed that oxLDL decreased EC-SOD mRNA and protein levels by binding to lectin-like oxidized LDL receptor-1 (LOX-1). Moreover, we demonstrated the significant role of mitogen-activated protein kinase (MEK)/extracellular-regulated protein kinase (ERK) signaling in oxLDL-elicited reductions in the expression of EC-SOD and proliferation of VSMCs. The results obtained with the FCS treatment indicate that oxLDL-elicited reductions in the expression of EC-SOD are related to the proliferation of VSMCs. We herein showed for the first time that luteolin, a natural product, restored oxLDL-induced decreases in the expression of EC-SOD and proliferation of VSMCs. Collectively, the results of the present study suggest that oxLDL accelerates the development of atherosclerosis by suppressing the expression of EC-SOD and also that luteolin has potential as a treatment for atherosclerosis. J. Cell. Biochem. 117: 2496-2505, 2016. © 2016 Wiley Periodicals, Inc.
内皮细胞和巨噬细胞产生的活性氧(ROS)在动脉粥样硬化形成过程中发挥着重要作用,因为它们会促进氧化型低密度脂蛋白(oxLDL)的形成。细胞外超氧化物歧化酶(EC-SOD)主要由血管平滑肌细胞(VSMC)产生,分泌到细胞外空间,并保护细胞免受超氧阴离子的损伤作用。因此,VSMC中EC-SOD的表达对于保护细胞免受动脉粥样硬化的影响至关重要;然而,oxLDL诱导的VSMC中EC-SOD表达的变化尚未得到研究。我们在此表明,oxLDL通过与凝集素样氧化型LDL受体-1(LOX-1)结合,降低了EC-SOD的mRNA和蛋白质水平。此外,我们证明了丝裂原活化蛋白激酶(MEK)/细胞外调节蛋白激酶(ERK)信号传导在oxLDL引起的EC-SOD表达降低和VSMC增殖中的重要作用。FCS处理的结果表明,oxLDL引起的EC-SOD表达降低与VSMC的增殖有关。我们在此首次表明,天然产物木犀草素可恢复oxLDL诱导的EC-SOD表达降低和VSMC增殖。总体而言,本研究结果表明,oxLDL通过抑制EC-SOD的表达加速动脉粥样硬化的发展,并且木犀草素具有作为动脉粥样硬化治疗药物的潜力。《细胞生物化学杂志》117: 2496 - 2505, 2016。© 2016威利期刊公司